Skip to main content
. 2021 Oct 13;1(1):30–40. doi: 10.1158/2767-9764.CRC-21-0060

FIGURE 1.

FIGURE 1

Overall survival among the total population (A) and among patients with localized leukoplakia (LL; B) and proliferative leukoplakia (PL). CFS among the total population (C) and among patients with localized leukoplakia and proliferative leukoplakia (D). Kaplan–Meier method, log-rank testing. *, P < 0.05.